Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye.

The mucus comes from the conjunctiva which is the transparent tissue covering the whites of the eye and internal surface of ...

With nearly 210 million individuals affected by dry eye syndrome globally, the demand for effective treatment solutions has surged significantly. The condition is particularly prevalent among aging ...

Restasis, AbbVie) at baseline,” Johnston said. Patients both with and without meibomian gland dysfunction (MGD) had been taking CsA 0.05% for at least 3 months, according to the study ...

Restasis to increase tear production, and other eye care products. Consolidated Edison is one of the largest investor-owned energy companies in the United States. This old-school utility stock ...

Late last week, Allergan announced it had sold a group of US patents for its $1.5 billion-a-year ophthalmology blockbuster Restasis (cyclosporine) to the Saint Regis Mohawk Tribe. In the bizarre ...

delivering 22x more cyclosporine to the cornea than competitor Restasis, and Harrow’s product already has a 92% refill rate likely because of its rapid onset, only twice daily dosing ...

Lying in wait at the moment are well-entrenched therapies like Novartis' Xiidra (lifitegrast) and AbbVie's Restasis (cyclosporine), which are not considered to be particularly effective and have ...